-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- News & Media
- News & Events
- Releases & Announcements
Releases & Announcements
In the Spotlight
Media Advisory: To Find Answers for People on Earth, NIH-Funded Tissue Chips Take Flight
NCATS, NIBIB, NIH ∙ 07/13/2022 ∙ Tissue Chip
Two NIH-funded research teams will send tissue chips to the International Space Station National Laboratory (ISS-NL). The tissue chips will spend several weeks in orbit to collect information about why the aging process causes muscles to lose mass and strength and the immune system to work less effectively.
July 2022
-
Media Advisory: To Find Answers for People on Earth, NIH-Funded Tissue Chips Take Flight
NCATS, NIBIB, NIH ∙ 07/13/2022 ∙ Tissue Chip
June 2022
-
Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
NCATS ∙ 06/02/2022 ∙ NCATS
May 2022
-
NIH Announces Antiviral Drug Development Awards
NIH ∙ 05/18/2022 ∙ Division of Preclinical Innovation -
Scientists Identify Characteristics to Better Define Long COVID
NCATS ∙ 05/17/2022 ∙ CTSA Program
April 2022
-
Researchers Create 3-D Model for Rare Neuromuscular Disorders, Setting Stage for Clinical Trial
NCATS ∙ 04/19/2022 ∙ SBIR/STIR, Tissue Chip
March 2022
-
Hydrocortisone Does Not Prevent Lung Complication in Extremely Preterm Infants
NICHD ∙ 03/23/2022 ∙ CTSA Program -
NCATS, Duke Scientists Show Compound’s Novel Effects on Key Brain Chemical in Drug Addiction
NCATS, Duke University ∙ 03/03/2022 ∙ Division of Preclinical Innovation
February 2022
-
NIH-Funded Study Suggests COVID-19 Increases Risk of Pregnancy Complications
NICHD ∙ 02/07/2022 ∙ CTSA Program
January 2022
-
Statement on NIH Study Testing Convalescent Plasma in Hospitalized Patients
NCATS, NIH ∙ 01/11/2022 ∙ CTSA Program
October 2021
-
NIH, FDA and 15 Private Organizations Join Forces to Increase Effective Gene Therapies for Rare Diseases
NCATS, NIH ∙ 10/27/2021 ∙ Bespoke Gene Therapy Consortium -
NIH Study Suggests People with Rare Diseases Face Significantly Higher Health Care Costs
NCATS ∙ 10/22/2021 ∙ Rare Diseases -
Oxytocin Does Not Improve Social Functioning in Children with Autism Spectrum Disorder, NIH-Funded Study Suggests
NICHD ∙ 10/13/2021 ∙ CTSA Program
- Funding & Notices
-